← Back to Search

Hyperpolarized [13C]Pyruvate for Brain Metabolism (HP Brain Trial)

Phase < 1
Waitlist Available
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 through 60 years of age.
Healthy, with no neurological abnormalities.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurements made during study scan
Awards & highlights

HP Brain Trial Summary

This trial will develop a new MRI technique to better understand how the brain uses energy, which could helpdiagnose and treat neurological disorders.

HP Brain Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

HP Brain Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurements made during study scan
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurements made during study scan for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Development of 13C ratio maps in the brain of healthy participants

HP Brain Trial Design

1Treatment groups
Experimental Treatment
Group I: Hyperpolarized [13C]pyruvateExperimental Treatment1 Intervention
Hyperpolarized stable isotope injection ([13C]pyruvate) during magnetic resonance spectroscopic imaging

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,040 Previous Clinical Trials
1,048,078 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Dec 2024